Business Wire- ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes.
Recent Posts
A (Dog’s) Day in the Life at UPMC Enterprises
I’m a simple man; I need food, water, treats, and enough stimulation and hard work …
Read More →
The Benefits of Retrospectives
Across the world, Agile teams use retrospectives (‘retros’) to look back and discuss their progress …
Read More →